etrasimod

FDA Drug Profile — Velsipity

Drug Details

Generic Name
etrasimod
Brand Names
Velsipity
Application Number
NDA216956
Sponsor
U.S. Pharmaceuticals
NDC Codes
2
Dosage Forms
TABLET, FILM COATED
Routes
ORAL
Active Ingredients
ETRASIMOD ARGININE

Indications and Usage

1 INDICATIONS AND USAGE VELSIPITY is indicated for the treatment of moderately to severely active ulcerative colitis (UC) in adults. VELSIPITY is a sphingosine 1-phosphate receptor modulator indicated for the treatment of moderately to severely active ulcerative colitis in adults. ( 1 )